The GOLM1 gene is located on chromosome 9 (9q21.33) in humans . It encodes a protein that is approximately 400 amino acids in length and has a molecular weight of around 73 kDa . The protein consists of a single transmembrane domain, with the N-terminus located in the cytoplasm and the C-terminus in the lumen of the Golgi apparatus .
GOLM1 is involved in the processing and transport of proteins synthesized in the rough endoplasmic reticulum . It is particularly important in the post-translational modification of proteins, including glycosylation, which is essential for the proper functioning of many proteins . The expression of GOLM1 is upregulated in response to viral infections, suggesting a role in the cellular response to viral pathogens .
GOLM1 has been implicated in various diseases, particularly those affecting the liver. It is overexpressed in liver diseases such as autoimmune hepatitis and liver cancer . Elevated levels of GOLM1 have been observed in the blood of patients with liver cancer, making it a potential biomarker for the early detection of this disease . Additionally, GOLM1 is overexpressed in prostate cancer and lung adenocarcinoma .
Recombinant GOLM1 is produced using recombinant DNA technology, where the GOLM1 gene is cloned into an expression vector and introduced into a host cell, typically E. coli or mammalian cells . The host cells then produce the GOLM1 protein, which can be purified and used for various research and diagnostic purposes . Recombinant GOLM1 is valuable for studying the protein’s function, interactions, and role in disease, as well as for developing diagnostic assays and potential therapeutic interventions .